A SYSTEMATIC REVIEW ON THE NEW FUROSEMIDE SUBCUTANEOUS INFUSER FOR THE TREATMENT OF HEART FAILURE (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorSOUZA, AMANDA LIMA-
Autor(es): dc.contributor.authorBOAS, BARBARA VILAS-
Autor(es): dc.contributor.authorFREITAS, RAFAELA VOLPATO DE-
Autor(es): dc.contributor.authorLUZ, JOÃO HENRIQUE-
Autor(es): dc.contributor.authorSPADOTO, LARA BELTRAME-
Autor(es): dc.contributor.authorTAGLIANI, JULIE ANE BRUM-
Autor(es): dc.contributor.authorJÚNIOR, JAIR MAXIMIANO DA SILVA-
Autor(es): dc.contributor.authorPAIXÃO, DENISE GONÇALVES DA SILVA DA-
Autor(es): dc.contributor.authorBAITA, ELAINE APARECIDA LAZARONI-
Autor(es): dc.contributor.authorSERPA, DIOGO DOS SANTOS-
Autor(es): dc.contributor.authorLIMA, ELAINE MORAIS DE-
Autor(es): dc.contributor.authorMATTÉ, ISADORA LUÍSA DE PAIVA-
Data de aceite: dc.date.accessioned2023-05-29T15:45:21Z-
Data de disponibilização: dc.date.available2023-05-29T15:45:21Z-
Data de envio: dc.date.issued2023-04-02-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/730998-
Resumo: dc.description.abstractObjective to evaluate, through a systematic review, the favorable and unfavorable results of using the subcutaneous furosemide infuser in patients with heart failure (HF) Methods: An integrative review was carried out, using as criteria the search in the National Library of Medicine (PubMed) and Scientific Electronic Library Online (SciELO) databases using the descriptors (i) furosemide (ii) Heart failure, (iii) subcutaneous infuser, with the Boolean operator “AND”. Studies published from 2018 to 2023 were included. Results The FDA has approved Furoscix, a subcutaneous formulation of the loop diuretic furosemide administered through a single-use body infuser, for the treatment of congestion, its safety and efficacy for use have been demonstrated at a dose of 30 mg SC over 1 hour, therefore after 12.5mg/h in the next 4 hours and the bioavailability was 99.6% compared to intravenous furosemide with two separate doses of 40mg, according to studies the health costs associated with heart failure were significantly lower in the groups that used the furosix.pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectFurosemidept_BR
Título: dc.titleA SYSTEMATIC REVIEW ON THE NEW FUROSEMIDE SUBCUTANEOUS INFUSER FOR THE TREATMENT OF HEART FAILURE (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais